4//SEC Filing
Atara Biotherapeutics, Inc. 4
Accession 0001209191-14-064490
$ATRACIK 0001604464operating
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 4:21 PM ET
Size
27.2 KB
Accession
0001209191-14-064490
Insider Transaction Report
Form 4
DAG Ventures Management V, LLC
10% Owner
Transactions
- Conversion
Common Stock
2014-10-21+4,634→ 4,634 total(indirect: see footnote) - Conversion
Series B Preferred
2014-10-21−1,519→ 0 total(indirect: see footnote)→ Common Stock (1,519 underlying) - Conversion
Common Stock
2014-10-21+1,902,798→ 1,902,798 total(indirect: see footnote) - Conversion
Series B Preferred
2014-10-21−623,863→ 0 total(indirect: see footnote)→ Common Stock (623,863 underlying) - Conversion
Series A Preferred
2014-10-21−1,278,935→ 0 total(indirect: see footnote)→ Common Stock (1,278,935 underlying) - Conversion
Series A Preferred
2014-10-21−3,115→ 0 total(indirect: see footnote)→ Common Stock (3,115 underlying)
Pianim Nicholas K.
10% Owner
Transactions
- Conversion
Common Stock
2014-10-21+4,634→ 4,634 total(indirect: see footnote) - Conversion
Common Stock
2014-10-21+1,902,798→ 1,902,798 total(indirect: see footnote) - Conversion
Series A Preferred
2014-10-21−1,278,935→ 0 total(indirect: see footnote)→ Common Stock (1,278,935 underlying) - Conversion
Series A Preferred
2014-10-21−3,115→ 0 total(indirect: see footnote)→ Common Stock (3,115 underlying) - Conversion
Series B Preferred
2014-10-21−623,863→ 0 total(indirect: see footnote)→ Common Stock (623,863 underlying) - Conversion
Series B Preferred
2014-10-21−1,519→ 0 total(indirect: see footnote)→ Common Stock (1,519 underlying)
DAG Ventures V-QP, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2014-10-21+4,634→ 4,634 total(indirect: see footnote) - Conversion
Series B Preferred
2014-10-21−1,519→ 0 total(indirect: see footnote)→ Common Stock (1,519 underlying) - Conversion
Common Stock
2014-10-21+1,902,798→ 1,902,798 total(indirect: see footnote) - Conversion
Series A Preferred
2014-10-21−1,278,935→ 0 total(indirect: see footnote)→ Common Stock (1,278,935 underlying) - Conversion
Series B Preferred
2014-10-21−623,863→ 0 total(indirect: see footnote)→ Common Stock (623,863 underlying) - Conversion
Series A Preferred
2014-10-21−3,115→ 0 total(indirect: see footnote)→ Common Stock (3,115 underlying)
DAG Ventures V, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2014-10-21+1,902,798→ 1,902,798 total(indirect: see footnote) - Conversion
Series A Preferred
2014-10-21−1,278,935→ 0 total(indirect: see footnote)→ Common Stock (1,278,935 underlying) - Conversion
Common Stock
2014-10-21+4,634→ 4,634 total(indirect: see footnote) - Conversion
Series A Preferred
2014-10-21−3,115→ 0 total(indirect: see footnote)→ Common Stock (3,115 underlying) - Conversion
Series B Preferred
2014-10-21−1,519→ 0 total(indirect: see footnote)→ Common Stock (1,519 underlying) - Conversion
Series B Preferred
2014-10-21−623,863→ 0 total(indirect: see footnote)→ Common Stock (623,863 underlying)
Cadeddu John J.
10% Owner
Transactions
- Conversion
Common Stock
2014-10-21+1,902,798→ 1,902,798 total(indirect: see footnote) - Conversion
Series A Preferred
2014-10-21−1,278,935→ 0 total(indirect: see footnote)→ Common Stock (1,278,935 underlying) - Conversion
Series A Preferred
2014-10-21−3,115→ 0 total(indirect: see footnote)→ Common Stock (3,115 underlying) - Conversion
Common Stock
2014-10-21+4,634→ 4,634 total(indirect: see footnote) - Conversion
Series B Preferred
2014-10-21−1,519→ 0 total(indirect: see footnote)→ Common Stock (1,519 underlying) - Conversion
Series B Preferred
2014-10-21−623,863→ 0 total(indirect: see footnote)→ Common Stock (623,863 underlying)
Goodrich R. Thomas
10% Owner
Transactions
- Conversion
Series A Preferred
2014-10-21−1,278,935→ 0 total(indirect: see footnote)→ Common Stock (1,278,935 underlying) - Conversion
Series B Preferred
2014-10-21−623,863→ 0 total(indirect: see footnote)→ Common Stock (623,863 underlying) - Conversion
Series A Preferred
2014-10-21−3,115→ 0 total(indirect: see footnote)→ Common Stock (3,115 underlying) - Conversion
Series B Preferred
2014-10-21−1,519→ 0 total(indirect: see footnote)→ Common Stock (1,519 underlying) - Conversion
Common Stock
2014-10-21+1,902,798→ 1,902,798 total(indirect: see footnote) - Conversion
Common Stock
2014-10-21+4,634→ 4,634 total(indirect: see footnote)
Chung Young J.
10% Owner
Transactions
- Conversion
Common Stock
2014-10-21+1,902,798→ 1,902,798 total(indirect: see footnote) - Conversion
Common Stock
2014-10-21+4,634→ 4,634 total(indirect: see footnote) - Conversion
Series A Preferred
2014-10-21−1,278,935→ 0 total(indirect: see footnote)→ Common Stock (1,278,935 underlying) - Conversion
Series B Preferred
2014-10-21−623,863→ 0 total(indirect: see footnote)→ Common Stock (623,863 underlying) - Conversion
Series B Preferred
2014-10-21−1,519→ 0 total(indirect: see footnote)→ Common Stock (1,519 underlying) - Conversion
Series A Preferred
2014-10-21−3,115→ 0 total(indirect: see footnote)→ Common Stock (3,115 underlying)
Williams Greg
10% Owner
Transactions
- Conversion
Series A Preferred
2014-10-21−3,115→ 0 total(indirect: see footnote)→ Common Stock (3,115 underlying) - Conversion
Series B Preferred
2014-10-21−1,519→ 0 total(indirect: see footnote)→ Common Stock (1,519 underlying) - Conversion
Common Stock
2014-10-21+1,902,798→ 1,902,798 total(indirect: see footnote) - Conversion
Common Stock
2014-10-21+4,634→ 4,634 total(indirect: see footnote) - Conversion
Series A Preferred
2014-10-21−1,278,935→ 0 total(indirect: see footnote)→ Common Stock (1,278,935 underlying) - Conversion
Series B Preferred
2014-10-21−623,863→ 0 total(indirect: see footnote)→ Common Stock (623,863 underlying)
Footnotes (3)
- [F1]All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock on a 1:1 basis upon the closing of the Issuer's initial public offering for no additional consideration and had no expiration date.
- [F2]The shares are held by DAG Ventures V-QP, L.P. DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu, Chung, Goodrich, Pianim and Williams are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP except to the extent of his or its proportionate pecuniary interest therein.
- [F3]The shares are held by DAG Ventures V, L.P. DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V and may be deemed to have indirect beneficial ownership of the securities held by DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu, Chung, Goodrich, Pianim and Williams are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V except to the extent of his or its proportionate pecuniary interest therein.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001604464
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 4:21 PM ET
- Size
- 27.2 KB